V20: STATE CODE
| Value | Label | Unweighted Frequency | % |
|---|---|---|---|
| 1 | MAINE | 11 | 2.2% |
| 2 | NEW HAMPSHIRE | 2 | 0.4% |
| 3 | VERMONT | 1 | 0.2% |
| 4 | MASSACHUSETTS | 15 | 3.0% |
| 5 | CONNECTICUT | 8 | 1.6% |
| 6 | RHODE ISLAND | 1 | 0.2% |
| 7 | NEW YORK | 31 | 6.1% |
| 8 | NEW JERSEY | 17 | 3.4% |
| 9 | PENNSYLVANIA | 27 | 5.3% |
| 10 | OHIO | 24 | 4.7% |
| 11 | INDIANA | 11 | 2.2% |
| 12 | ILLINOIS | 24 | 4.7% |
| 13 | MICHIGAN | 24 | 4.7% |
| 14 | WISCONSIN | 10 | 2.0% |
| 15 | MINNESOTA | 8 | 1.6% |
| 16 | IOWA | 9 | 1.8% |
| 17 | MISSOURI | 10 | 2.0% |
| 18 | KANSAS | 5 | 1.0% |
| 19 | NEBRASKA | 3 | 0.6% |
| 20 | SOUTH DAKOTA | 0 | 0.0% |
| 21 | NORTH DAKOTA | 3 | 0.6% |
| 22 | DELAWARE | 2 | 0.4% |
| 23 | MARYLAND | 6 | 1.2% |
| 24 | DISTRICT OF COLUMBIA | 3 | 0.6% |
| 25 | WEST VIRGINIA | 6 | 1.2% |
| 26 | VIRGINIA | 20 | 3.9% |
| 27 | NORTH CAROLINA | 13 | 2.6% |
| 28 | SOUTH CAROLINA | 8 | 1.6% |
| 29 | GEORGIA | 16 | 3.2% |
| 30 | FLORIDA | 18 | 3.6% |
| 31 | MISSISSIPPI | 6 | 1.2% |
| 32 | ALABAMA | 5 | 1.0% |
| 33 | TENNESSEE | 8 | 1.6% |
| 34 | KENTUCKY | 6 | 1.2% |
| 35 | ARKANSAS | 4 | 0.8% |
| 36 | LOUISIANA | 8 | 1.6% |
| 37 | TEXAS | 29 | 5.7% |
| 38 | OKLAHOMA | 9 | 1.8% |
| 39 | NEW MEXICO | 1 | 0.2% |
| 40 | ARIZONA | 11 | 2.2% |
| 41 | NEVADA | 1 | 0.2% |
| 42 | UTAH | 8 | 1.6% |
| 43 | COLORADO | 5 | 1.0% |
| 44 | WYOMING | 3 | 0.6% |
| 45 | MONTANA | 3 | 0.6% |
| 46 | IDAHO | 3 | 0.6% |
| 47 | WASHINGTON | 8 | 1.6% |
| 48 | OREGON | 6 | 1.2% |
| 49 | CALIFORNIA | 47 | 9.3% |
| Total | 507 | 100% |
Based upon 507 valid cases out of 507 total cases.
Location: 77-78 (width: 2; decimal: 0)
Variable Type: numeric
(Range of) Valid Data Values: 1 thru 49
Notes
Source: This variable was taken from: ABC News Tylenol Poisoning Poll, February 1986.
Copyright: ICPSR has an FAQ on copyright and survey instruments.
Disclaimer: The frequencies for this variable may not be weighted. They are purely descriptive and may not be representative of the study population. Please use with caution and consult the study documentation.